Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Perry M Elliott

Showing results (201-210 of 292) with videos related to

Pageof 30
Sort By:
JAMA Cardiology|January 18, 2023
Effects of Mavacamten on Measures of Cardiopulmonary Exercise Testing Beyond Peak Oxygen Consumption: A Secondary Analysis of the EXPLORER-HCM Randomized TrialMatthew T Wheeler, Iacopo Olivotto, Perry M Elliott, et al.
International Journal of Cardiology|November 24, 2023
Corrigendum to 'Syncope in hypertrophic cardiomyopathy (part II): An expert consensus statement on the diagnosis and management' [International Journal of Cardiology, 2023, 41:180-186]Michele Brignole, Franco Cecchi, Aris Anastasakis, et al.
International Journal of Cardiology|October 29, 2022
Syncope in hypertrophic cardiomyopathy (part II): An expert consensus statement on the diagnosis and managementMichele Brignole, Franco Cecchi, Aris Anastasakis, et al.
Clinical Genetics|April 27, 2020
Deletions of specific exons of FHOD3 detected by next-generation sequencing are associated with hypertrophic cardiomyopathyJuan P Ochoa, Luis R Lopes, Marlene Perez-Barbeito, et al.
Molecular Genetics and Metabolism Reports|February 19, 2019
The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: A systematic literature review by a European panel of expertsDominique P Germain, Perry M Elliott, Bruno Falissard, et al.
European Heart Journal. Cardiovascular Imaging|July 19, 2019
Dilated cardiomyopathy and arrhythmogenic left ventricular cardiomyopathy: a comprehensive genotype-imaging phenotype studyJoão B Augusto, Rocio Eiros, Eleni Nakou, et al.
Circulation|March 3, 2020
Evidence From Family Studies for Autoimmunity in Arrhythmogenic Right Ventricular Cardiomyopathy: Associations of Circulating Anti-Heart and Anti-Intercalated Disk Autoantibodies With Disease Severity and Family HistoryAlida L P Caforio, Federica Re, Andrea Avella, et al.
Kardiologia Polska|August 18, 2018
[2018 ESC Guidelines for the diagnosis and management of syncope]Michele Brignole, Angel Moya, Frederik J de Lange, et al.
Molecular Genetics and Metabolism|October 22, 2003
Mutations in the muscle LIM protein and alpha-actinin-2 genes in dilated cardiomyopathy and endocardial fibroelastosisBhagyalaxmi Mohapatra, Shinawe Jimenez, Jiuann Huey Lin, et al.
Journal of the American College of Cardiology|December 17, 2021
Effect of Mavacamten on Echocardiographic Features in Symptomatic Patients With Obstructive Hypertrophic CardiomyopathySheila M Hegde, Steven J Lester, Scott D Solomon, et al.
Pageof 30

Showing results (201-210 of 292) with videos related to

Sort By:
Pageof 30
JAMA Cardiology|January 18, 2023
Effects of Mavacamten on Measures of Cardiopulmonary Exercise Testing Beyond Peak Oxygen Consumption: A Secondary Analysis of the EXPLORER-HCM Randomized TrialMatthew T Wheeler, Iacopo Olivotto, Perry M Elliott, et al.
International Journal of Cardiology|November 24, 2023
Corrigendum to 'Syncope in hypertrophic cardiomyopathy (part II): An expert consensus statement on the diagnosis and management' [International Journal of Cardiology, 2023, 41:180-186]Michele Brignole, Franco Cecchi, Aris Anastasakis, et al.
International Journal of Cardiology|October 29, 2022
Syncope in hypertrophic cardiomyopathy (part II): An expert consensus statement on the diagnosis and managementMichele Brignole, Franco Cecchi, Aris Anastasakis, et al.
Clinical Genetics|April 27, 2020
Deletions of specific exons of FHOD3 detected by next-generation sequencing are associated with hypertrophic cardiomyopathyJuan P Ochoa, Luis R Lopes, Marlene Perez-Barbeito, et al.
Molecular Genetics and Metabolism Reports|February 19, 2019
The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: A systematic literature review by a European panel of expertsDominique P Germain, Perry M Elliott, Bruno Falissard, et al.
European Heart Journal. Cardiovascular Imaging|July 19, 2019
Dilated cardiomyopathy and arrhythmogenic left ventricular cardiomyopathy: a comprehensive genotype-imaging phenotype studyJoão B Augusto, Rocio Eiros, Eleni Nakou, et al.
Circulation|March 3, 2020
Evidence From Family Studies for Autoimmunity in Arrhythmogenic Right Ventricular Cardiomyopathy: Associations of Circulating Anti-Heart and Anti-Intercalated Disk Autoantibodies With Disease Severity and Family HistoryAlida L P Caforio, Federica Re, Andrea Avella, et al.
Kardiologia Polska|August 18, 2018
[2018 ESC Guidelines for the diagnosis and management of syncope]Michele Brignole, Angel Moya, Frederik J de Lange, et al.
Molecular Genetics and Metabolism|October 22, 2003
Mutations in the muscle LIM protein and alpha-actinin-2 genes in dilated cardiomyopathy and endocardial fibroelastosisBhagyalaxmi Mohapatra, Shinawe Jimenez, Jiuann Huey Lin, et al.
Journal of the American College of Cardiology|December 17, 2021
Effect of Mavacamten on Echocardiographic Features in Symptomatic Patients With Obstructive Hypertrophic CardiomyopathySheila M Hegde, Steven J Lester, Scott D Solomon, et al.
Pageof 30